Introgen Therapeutics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Introgen Therapeutics

INGN 8.065

-1.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (64)	5/18/2004 2:37:51 PM
From: Jibacoa	Read Replies (2) of 802

INGN was in yesterday's WSJ list of the best recommendations in 2003 by the 10 top-performing No.1 analysts in its "Best of the Sreet" survey. The 268% gain wasn't as good as some that were made in SI's Biotech picking contest, but was the best entry in the WSJ Biotech survey. BTW, those that participate in the SI contest this year should know that entries for ELN have been disqualified because of the “major accounting problems” that drew the attention of the SEC have not been properly and fully investigated.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next